Physician profile
Benjamin Campbell
NPI 1962658898
$1,678.99
in general payments reported to CMS, 2019-2025
11 companies · $440 in 2025
The $440 reported for 2025 was more than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $301 · 2022: $123 · 2023: $573 · 2024: $242 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,254.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teva Pharmaceuticals USA, INC. | $232.37 | 2021-2024 | Austedo Xr |
| Axsome Therapeutics, INC. | $230.56 | 2025 | Auvelity |
| Novo Nordisk INC | $230.10 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $205.17 | 2021-2023 | Tezspire |
| Idorsia Pharmaceuticals US INC | $193.90 | 2023-2025 | Quviviq, Tryvio |
| Alexion Pharmaceuticals, INC. | $128.56 | 2023 | |
| Lilly USA, LLC | $120.12 | 2024 | Zepbound |
| Sanofi-Aventis U.S. LLC | $112.79 | 2025 | |
| Corcept Therapeutics | $99.04 | 2023 | Korlym |
| Scpharmaceuticals INC. | $98.56 | 2023 | |
| Coloplast Corp | $27.82 | 2023 | Titan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.